BeOne Medicines (BEIGF) Amortization - Intangibles (2017 - 2023)
BeOne Medicines (BEIGF) reported Amortization - Intangibles of -$782000.0 for Q4 2023, up 65.34% year-over-year from -$472973.7 in Q4 2022, and down 160.76% quarter-over-quarter from $1.3 million in Q3 2023.
BeOne Medicines (BEIGF) Amortization - Intangibles (2017 - 2023) Analysis & Trends
BeOne Medicines (BEIGF) has 7 years of Amortization - Intangibles data on file, last reported at -$782000.0 in Q4 2023.
- Amortization - Intangibles for Q4 2023 came in at -$782000.0, up 65.34% year-over-year; the trailing twelve-month figure through Jun 2024 was $505000.0 (up 1018.18% YoY), and the FY2023 annual result was $3.5 million, up 366.05% from the prior year.
- Amortization - Intangibles fell to -$782000.0 in Q4 2023 per BEIGF's latest filing, from $1.3 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $1.3 million in Q3 2023 and troughed at -$2.3 million in Q4 2022.
- A 5-year average of $204050.0 and a median of $235500.0 in 2020 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles tumbled 1306.42% in 2022, then jumped 588.24% in 2023.
- A 5-year view of Amortization - Intangibles shows it stood at $332000.0 in 2019, then plunged by 43.37% to $188000.0 in 2020, then decreased by 0.53% to $187000.0 in 2021, then plunged by 1306.42% to -$2.3 million in 2022, then jumped by 65.34% to -$782000.0 in 2023.
- Business Quant data shows BEIGF's Amortization - Intangibles at -$782000.0 in Q4 2023, $1.3 million in Q3 2023, and $1.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -782,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 986,000.00 |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 187,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 187,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Sep 30, 2020 | 187,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 283,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 331,000.00 |
| Jun 30, 2019 | 332,000.00 |
| Mar 31, 2019 | 331,000.00 |